Back to search

Article

Network-based Approach to Identify Prognosis-related Genes in Tamoxifen-treated Patients With Estrogen Receptor-positive Breast Cancer

2020-07-06

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> The estrogen receptor (ER) antagonist tamoxifen is the most commonly used endocrine therapy for ER-positive breast cancer. However, tamoxifen resistance remains a major cause of cancer recurrence and progression. Here, we aimed to identify hub genes involved in the progression and prognosis of ER-positive breast cancer following tamoxifen treatment.<bold>Results...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0be1af31-d564-5569-abb2-2c135b8a3a3d
DOI
10.21203/rs.3.rs-39426/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Network-based Approach to Identify Prognosis-related Genes in Tamoxifen-treated Patients With Estrogen Receptor-positive Breast CancerDOI 10.21203/rs.3.rs-39426/v1
Identification of hub genes affecting triple-negative breast cancer using bioinformatics analysis strategiesSemantic proximity
Exploring the Molecular Mechanism of the Drug-Treated Breast Cancer Based on Gene Expression MicroarraySemantic proximity
Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision MedicineSemantic proximity
Investigation of the Genomic and Transcriptomic Variations Underlying Tamoxifen Resistance in Breast CancerSemantic proximity
Transcriptome profiling identified differentially expressed genes and pathways associated with tamoxifen resistance in human breast cancerSemantic proximity
Construction and Identification of a Novel 5-Gene Signature for Predicting the Prognosis in Breast CancerSemantic proximity
Integrated transcriptomic meta-analysis provides novel insights into breast cancer molecular subtypesSemantic proximity
Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancerSemantic proximity
Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast CancerSemantic proximity
Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools.Semantic proximity
Identification of Seven Hub Genes as the Novel Biomarkers in Triple-negative Breast Cancer and Breast Cancer MetastasisSemantic proximity
Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapySemantic proximity
Select a neighboring publication to make it the new centre.